Weaver C. Barksdale & Associates’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-19,351
Closed -$1.29M 525
2017
Q1
$1.29M Buy
19,351
+5,226
+37% +$348K 1.52% 37
2016
Q4
$922K Buy
14,125
+4,868
+53% +$316K 1.49% 39
2016
Q3
$655K Buy
9,257
+1,039
+13% +$75.7K 1.1% 55
2016
Q2
$608K Hold
8,218
1.06% 55
2016
Q1
$533K Sell
8,218
-103
-1% -$7.01K 0.4% 85
2015
Q4
$642K Hold
8,321
0.5% 77
2015
Q3
$685K Hold
8,321
0.55% 69
2015
Q2
$733K Hold
8,321
0.54% 73
2015
Q1
$735K Sell
8,321
-204
-2% -$18.1K 0.55% 69
2014
Q4
$708K Sell
8,525
-391
-4% -$32.4K 0.57% 76
2014
Q3
$752K Hold
8,916
0.62% 57
2014
Q2
$723K Buy
8,916
+3,125
+54% +$246K 0.58% 65
2014
Q1
$441K Sell
5,791
-318
-5% -$23.2K 0.37% 80
2013
Q4
$440K Sell
6,109
-148
-2% -$10.3K 0.37% 78
2013
Q3
$430K Buy
6,257
+4,715
+306% +$312K 0.39% 68
2013
Q2
$98K Buy
+1,542
New +$100K 0.1% 110

Other funds holding NVS